| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 28.04▲ | 27.84▲ | 27.94▲ | 24.96▲ | 25.77▲ |
| MA10 | 28.06▲ | 27.96▲ | 28.14▼ | 24.71▲ | 26.87▲ |
| MA20 | 27.86▲ | 28.03▲ | 26.21▲ | 25.78▲ | 26.94▲ |
| MA50 | 27.88▲ | 25.22▲ | 24.69▲ | 27.24▲ | 33.10▼ |
| MA100 | 28.21▼ | 24.72▲ | 25.10▲ | 26.97▲ | N/A |
| MA200 | 26.63▲ | 25.19▲ | 26.68▲ | 33.46▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.032▲ | -0.218▼ | 0.081▲ | 0.293▲ | -0.003▼ |
| RSI | 57.634▲ | 61.447▲ | 68.239▲ | 58.576▲ | 49.317▼ |
| STOCH | 76.461 | 23.710 | 41.069 | 32.465 | 27.233 |
| WILL %R | -17.213▲ | -76.638▼ | -34.479 | -22.864▲ | -46.839 |
| CCI | 69.896 | -19.987 | 28.455 | 180.607▲ | -49.645 |
| CDL | $MAZE Harami Candlestick Pattern Detected | Set Alert |
|
Wednesday, September 23, 2026 05:48 AM
Maze Therapeutics (NASDAQ:MAZE) shares rose 2.9% in pre-market trading after CIBC initiated coverage of the clinical-stage biopharmaceutical company with an Outperformer rating and a $50 price target.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/09/26 | 28.30 | 29.91 | 27.53 | 28.09 | 1,704,038 |
| 22/09/26 | 24.52 | 29.40 | 24.50 | 28.38 | 3,565,873 |
| 21/09/26 | 22.52 | 23.015 | 21.95 | 22.39 | 516,967 |
| 18/09/26 | 23.27 | 23.565 | 22.01 | 22.52 | 1,494,806 |
| 17/09/26 | 24.38 | 24.80 | 23.27 | 23.44 | 363,522 |
| 16/09/26 | 24.33 | 24.72 | 23.74 | 23.915 | 385,672 |
| 15/09/26 | 24.63 | 24.795 | 24.00 | 24.23 | 437,398 |
| 14/09/26 | 24.90 | 25.85 | 24.46 | 24.67 | 589,281 |
| 11/09/26 | 25.14 | 25.99 | 24.36 | 24.60 | 1,052,238 |
| 10/09/26 | 24.26 | 25.62 | 23.9401 | 24.82 | 1,181,276 |
|
|
||||
|
|
||||
|
|